sentence1 stringlengths 1.08k 96.5k | sentence2 stringlengths 51 966 | labels stringclasses 3
values | metadata stringlengths 123 2.56k |
|---|---|---|---|
Background
The number of routine antenatal visits provided to low risk nulliparous women has been reduced in the UK, acknowledging this change in care may result in women being less satisfied with their care and having poorer psychosocial outcomes. The primary aim of the study was to investigate whether the provision ... | Intervention: received calls from a midwife at 28, 33 and 36 weeks and additional UADS at 20 weeks’ gestation
Comparator: received calls from a midwife at 28, 33 and 36 weeks
Outcome: the numbers of routine and unscheduled visits | 0 | {"evidence_spans": [{"end": 21186, "start": 20926, "text": "7)\r\n-0.06-0.09\r\n0.78\r\n33\u00a0weeks\r\n170 (60.2)\r\n166 (60.3)\r\n-0.08-0.08\r\n0.98\r\n\u00a0\r\n37\u00a0weeks\r\n150 (53.5)\r\n143 (52.0)\r\n-0.09-0.07\r\n0.77\r\nThe differences between the groups in the total number of antenatal visits received afte... |
Background
The number of routine antenatal visits provided to low risk nulliparous women has been reduced in the UK, acknowledging this change in care may result in women being less satisfied with their care and having poorer psychosocial outcomes. The primary aim of the study was to investigate whether the provision ... | Intervention: received calls from a midwife at 28, 33 and 36 weeks and additional UADS at 20 weeks’ gestation
Comparator: received calls from a midwife at 28, 33 and 36 weeks
Outcome: the level of state anxiety | 0 | {"evidence_spans": [{"end": 22843, "start": 22676, "text": " positive result at 20\u00a0weeks accessed the same number of visits (routine: 7; unscheduled: 2) when compared to the rest of the study population.\r\nDifferences between th"}, {"end": 22854, "start": 22676, "text": " positive result at 20\u00a0weeks accessed... |
Background
The number of routine antenatal visits provided to low risk nulliparous women has been reduced in the UK, acknowledging this change in care may result in women being less satisfied with their care and having poorer psychosocial outcomes. The primary aim of the study was to investigate whether the provision ... | Intervention: received calls from a midwife at 28, 33 and 36 weeks and additional UADS at 20 weeks’ gestation
Comparator: received calls from a midwife at 28, 33 and 36 weeks
Outcome: levels of satisfaction | 0 | {"evidence_spans": [{"end": 24149, "start": 24040, "text": "\r\nThe levels of social support did not alter during pregnancy or six weeks after birth with mean scores indic"}], "id": "12658", "pmcid": "4021157", "prompt_id": "12658", "split_group_id": "4021157", "votes": {"0": 2}} |
Background
The number of routine antenatal visits provided to low risk nulliparous women has been reduced in the UK, acknowledging this change in care may result in women being less satisfied with their care and having poorer psychosocial outcomes. The primary aim of the study was to investigate whether the provision ... | Intervention: received calls from a midwife at 28, 33 and 36 weeks and additional UADS at 20 weeks’ gestation
Comparator: received calls from a midwife at 28, 33 and 36 weeks
Outcome: the proportion of women who had a SGA baby (BW ≤ 10th centile) | 0 | {"evidence_spans": [{"end": 25040, "start": 24748, "text": "e study was not powered to detect differences between the groups for clinical outcomes. Three out of five women who were screen positive at 24\u00a0weeks gestation delivered SGA infants and two of these women also had PIH. There were no clinically significant ... |
Background
Diagnostic self-tests are becoming increasingly available. Since the pros and cons of self-testing are unclear and neutral information on self-testing is lacking, two decision aids (DAs) on self-testing for cholesterol and diabetes were developed to support consumers in making an informed choice that is in ... | Intervention: interactive online DA with general information on self-testing and test-specific information on cholesterol or diabetes self-testing
Comparator: received a limited information sheet with general information on self-testing
Outcome: intention to use a cholesterol test | 0 | {"evidence_spans": [{"end": 23025, "start": 22923, "text": "\r\n37.6% (175)\r\n35.3% (85)\r\n40.2% (90)\r\n\r\nNote: aLow\u2009=\u2009primary and secondary school, Intermediate\u2009=\u2009int"}, {"end": 23032, "start": 22923, "text": "\r\n37.6% (175)\r\n35.3% (85)\r\n40.2% (90)\r\n\r\nNote: aLow\u2009=\u2009primary an... |
Background
Diagnostic self-tests are becoming increasingly available. Since the pros and cons of self-testing are unclear and neutral information on self-testing is lacking, two decision aids (DAs) on self-testing for cholesterol and diabetes were developed to support consumers in making an informed choice that is in ... | Intervention: interactive online DA with general information on self-testing and test-specific information on cholesterol or diabetes self-testing
Comparator: received a limited information sheet with general information on self-testing
Outcome: Time spent on the website | 1 | {"evidence_spans": [{"end": 31817, "start": 31270, "text": "terol or diabetes\r\nCholesterol\r\nWe found no significant effect of group on ambivalence at T1 (Table\u00a03).\r\nWe found ambivalence at baseline to be a significant predictor of ambivalence at T1, suggesting that participants who had a high level of ambiva... |
Objectives:
To determine and compare the effects of autologous platelet rich plasma (PRP) and hyaluronic acid (HA) for the treatment of osteoarthritis of the knee.
Methods:
This prospective study included 150 patients affected by severe osteoarthritis of the knee. Gonarthrosis was graded using the Kellgren-Lawrenc... | Intervention: three intraarticular injection of autologous platelet rich plasma (PRP)
Comparator: 3 intra-articular injections of high molecular weight hyaluronic acid (HA)
Outcome: WOMAC score and visual pain scale at 3 months and 6 months | -1 | {"evidence_spans": [{"end": 1112, "start": 953, "text": "served. Statistically significant better results in the WOMAC score and visual pain scale was determined in PRP group than HA group at 3 months and 6 months fo"}, {"end": 1113, "start": 954, "text": "erved. Statistically significant better results in the WOMAC sc... |
Objectives:
To determine and compare the effects of autologous platelet rich plasma (PRP) and hyaluronic acid (HA) for the treatment of osteoarthritis of the knee.
Methods:
This prospective study included 150 patients affected by severe osteoarthritis of the knee. Gonarthrosis was graded using the Kellgren-Lawrenc... | Intervention: three intraarticular injection of autologous platelet rich plasma (PRP)
Comparator: 3 intra-articular injections of high molecular weight hyaluronic acid (HA)
Outcome: WOMAC score and visual pain scale at 12 months | 0 | {"evidence_spans": [{"end": 1270, "start": 1196, "text": " group.At 12 months' of follow-up, PRP and HA treatments offered similar r"}], "id": "12663", "pmcid": "4595873", "prompt_id": "12663", "split_group_id": "4595873", "votes": {"0": 2}} |
Summary
Objective
To investigate the effects of monthly feedback of changes in visceral fat area (VFA) as measured by dual bioelectrical impedance analysis method and the importance of VFA in individuals with obesity.
Methods
Thirty‐eight Japanese patients with obesity underwent VFA measurements. The feedback gro... | Intervention: informed about results of visceral fat area (VFA)
Comparator: not informed about results of visceral fat area (VFA)
Outcome: changes in visceral fat area (VFA) (%) | 0 | {"evidence_spans": [{"end": 845, "start": 687, "text": "kg\u00a0m\u22122. At the 4\u2010month follow\u2010up, there was no significant difference in VFA reduction between the control and feedback groups (\u22124.4% vs. \u22123.0%; 95% CI, \u22123.8 "}, {"end": 14433, "start": 14241, "text": "he feedback group from base... |
Summary
Objective
To investigate the effects of monthly feedback of changes in visceral fat area (VFA) as measured by dual bioelectrical impedance analysis method and the importance of VFA in individuals with obesity.
Methods
Thirty‐eight Japanese patients with obesity underwent VFA measurements. The feedback gro... | Intervention: informed about results of visceral fat area (VFA)
Comparator: not informed about results of visceral fat area (VFA)
Outcome: BMI changes (%) | 0 | {"evidence_spans": [{"end": 14829, "start": 14647, "text": "roup and of the feedback group from baseline to the end of the study were not significant (\u22120.1 [1.3] [95%CI, \u22120.7 to 0.5]) and (0.04 [1.5] [95% CI, \u22120.7 to 0.8]), respectively. Ther"}], "id": "12665", "pmcid": "5729492", "prompt_id": "12665", "... |
Summary
Objective
To investigate the effects of monthly feedback of changes in visceral fat area (VFA) as measured by dual bioelectrical impedance analysis method and the importance of VFA in individuals with obesity.
Methods
Thirty‐eight Japanese patients with obesity underwent VFA measurements. The feedback gro... | Intervention: informed about results of visceral fat area (VFA)
Comparator: not informed about results of visceral fat area (VFA)
Outcome: WC changes (%) | 0 | {"evidence_spans": [{"end": 15052, "start": 14830, "text": " was no significant difference in BMI changes (%) from baseline to the end of the study between the control and feedback groups (\u22120.3 [4.6] vs. 0.04 [4.8]; 95% CI, \u22121.7 to 1.2). The changes of WC of the control group from "}, {"end": 15234, "start": ... |
Summary
Objective
To investigate the effects of monthly feedback of changes in visceral fat area (VFA) as measured by dual bioelectrical impedance analysis method and the importance of VFA in individuals with obesity.
Methods
Thirty‐eight Japanese patients with obesity underwent VFA measurements. The feedback gro... | Intervention: informed about results of visceral fat area (VFA)
Comparator: not informed about results of visceral fat area (VFA)
Outcome: The feeling of hunger/satiation | -1 | {"evidence_spans": [{"end": 17082, "start": 16924, "text": "seline and after 4 months using paired t\u2010test.\r\nBMI, body mass index; VFA, visceral fat area.\r\n\r\nQuestionnaire results at baseline and 4\u00a0months: control group"}], "id": "12668", "pmcid": "5729492", "prompt_id": "12668", "split_group_id": "57294... |
Introduction
Acute kidney injury (AKI) is associated with a high mortality of up to 60%. The mode of renal replacement therapy (intermittent versus continuous) has no impact on patient survival. Sustained low efficiency dialysis using a single-pass batch dialysis system (SLED-BD) has recently been introduced for the t... | Intervention: single-pass batch dialysis system (SLED-BD)
Comparator: continuous veno-venous hemofiltration (CVVH)
Outcome: Mortality at 90 days | 0 | {"evidence_spans": [{"end": 1250, "start": 1136, "text": "= 877).The primary outcome measure, 90-day mortality, was similar between groups (SLED: 49.6% vs. CVVH: 55.6%, P ="}, {"end": 16380, "start": 16265, "text": "quare test with Yates' correction. BP syst: systolic blood pressure; BP diast: diastolic blood pressure;... |
Introduction
Acute kidney injury (AKI) is associated with a high mortality of up to 60%. The mode of renal replacement therapy (intermittent versus continuous) has no impact on patient survival. Sustained low efficiency dialysis using a single-pass batch dialysis system (SLED-BD) has recently been introduced for the t... | Intervention: single-pass batch dialysis system (SLED-BD)
Comparator: continuous veno-venous hemofiltration (CVVH)
Outcome: effective blood flow | 1 | {"evidence_spans": [{"end": 16463, "start": 16381, "text": "ined low efficiency dialysis; CVVH: continuous veno-venous hemofiltration.\r\nFigure"}, {"end": 16512, "start": 16381, "text": "ined low efficiency dialysis; CVVH: continuous veno-venous hemofiltration.\r\nFigure 2Probabilities of survival in sustained low eff... |
Introduction
Acute kidney injury (AKI) is associated with a high mortality of up to 60%. The mode of renal replacement therapy (intermittent versus continuous) has no impact on patient survival. Sustained low efficiency dialysis using a single-pass batch dialysis system (SLED-BD) has recently been introduced for the t... | Intervention: single-pass batch dialysis system (SLED-BD)
Comparator: continuous veno-venous hemofiltration (CVVH)
Outcome: The nursing time spent | -1 | {"evidence_spans": [{"end": 1719, "start": 1515, "text": "0.04). Patients treated with SLED needed fewer blood transfusions (1,375 \u00b1 2,573 ml vs. 1,976 \u00b1 3,316 ml, P = 0.02) and had a substantial reduction in nursing time spent for renal replacement therapy (P <"}, {"end": 18751, "start": 18644, "text": "117)... |
Introduction
Acute kidney injury (AKI) is associated with a high mortality of up to 60%. The mode of renal replacement therapy (intermittent versus continuous) has no impact on patient survival. Sustained low efficiency dialysis using a single-pass batch dialysis system (SLED-BD) has recently been introduced for the t... | Intervention: single-pass batch dialysis system (SLED-BD)
Comparator: continuous veno-venous hemofiltration (CVVH)
Outcome: Duration of mechanical ventilation and of ICU-stay , and time to renal recovery | -1 | {"evidence_spans": [{"end": 1514, "start": 1322, "text": "hereas patients in the SLED-BD group had significantly fewer days of mechanical ventilation (17.7 \u00b1 19.4 vs. 20.9 \u00b1 19.8, P = 0.047) and fewer days in the ICU (19.6 \u00b1 20.1 vs. 23.7 \u00b1 21.9, P ="}, {"end": 17007, "start": 16838, "text": "w (P <... |
Introduction
Acute kidney injury (AKI) is associated with a high mortality of up to 60%. The mode of renal replacement therapy (intermittent versus continuous) has no impact on patient survival. Sustained low efficiency dialysis using a single-pass batch dialysis system (SLED-BD) has recently been introduced for the t... | Intervention: single-pass batch dialysis system (SLED-BD)
Comparator: continuous veno-venous hemofiltration (CVVH)
Outcome: The quantity of blood transfusions | -1 | {"evidence_spans": [{"end": 18098, "start": 17926, "text": "within the recommended dose for CVVH treatment [19]. Solute clearance (as demonstrated by urea and phosphate values) was more effective in the SLED-treated patients than in"}], "id": "12673", "pmcid": "3580725", "prompt_id": "12673", "split_group_id": "3580725... |
Background
Neuromuscular electrostimulation has become a promising issue in cardiovascular rehabilitation. However there are few articles published in the literature regarding neuromuscular electrostimulation in patients with heart failure during hospital stay.
Methods
This is a randomized controlled pilot trial t... | Intervention: 60 minutes of electrostimulation (wave frequency was 20 Hz, pulse duration of 20 us) two times a day
Comparator: conventional rehabilitation
Outcome: the walked distance in the six-minute walking test | 1 | {"evidence_spans": [{"end": 1125, "start": 826, "text": "sults\r\nThe walked distance in the six-minute walking test improved 75% in the electrostimulation group (from 379.7 \u00b1 43.5 to 372.9 \u00b1 46.9 meters to controls and from 372.9 \u00b1 62.4 to 500 \u00b1 68 meters to electrostimulation, p<0.001). On the oth... |
Background
Neuromuscular electrostimulation has become a promising issue in cardiovascular rehabilitation. However there are few articles published in the literature regarding neuromuscular electrostimulation in patients with heart failure during hospital stay.
Methods
This is a randomized controlled pilot trial t... | Intervention: 60 minutes of electrostimulation (wave frequency was 20 Hz, pulse duration of 20 us) two times a day
Comparator: conventional rehabilitation
Outcome: blood lactate and venous saturation of oxygen | -1 | {"evidence_spans": [{"end": 9974, "start": 9850, "text": "nous oxygen saturation.\r\nOur secondary end-points showed the same behavior than the walked distance in the six-minute walkin"}, {"end": 10085, "start": 9850, "text": "nous oxygen saturation.\r\nOur secondary end-points showed the same behavior than the walked ... |
Background
Several previous studies have suggested the improvement of atopic dermatitis (AD) in response to special fabrics. In particular, beneficial effects have been reported, following the use of anion textiles.
Objective
The purpose of this study is to evaluate the effectiveness and safety of an anion textile... | Intervention: anion textile
Comparator: pure cotton
Outcome: mean SCORAD index | -1 | {"evidence_spans": [{"end": 7864, "start": 7523, "text": "\r\nClinical efficacy using SCORAD index\r\nIn patients from group A who wore the anion textile garment, the mean SCORAD index decreased significantly from 47.2\u00b114.0 to 36.1\u00b116.5 (p<0.0001), compared to the baseline. In contrast, the mean SCORAD index ... |
Background
Several previous studies have suggested the improvement of atopic dermatitis (AD) in response to special fabrics. In particular, beneficial effects have been reported, following the use of anion textiles.
Objective
The purpose of this study is to evaluate the effectiveness and safety of an anion textile... | Intervention: anion textile
Comparator: pure cotton
Outcome: the mean TEWL from eczematous lesions | -1 | {"evidence_spans": [{"end": 8935, "start": 8752, "text": "0.0064).\r\n\r\nBarrier functions of the skin\r\nThe mean TEWL from eczematous lesions on the flexor surface of the forearm for group A decreased significantly, compared to the baseline fro"}, {"end": 9186, "start": 8752, "text": "0.0064).\r\n\r\nBarrier functio... |
Background
Several previous studies have suggested the improvement of atopic dermatitis (AD) in response to special fabrics. In particular, beneficial effects have been reported, following the use of anion textiles.
Objective
The purpose of this study is to evaluate the effectiveness and safety of an anion textile... | Intervention: anion textile
Comparator: pure cotton
Outcome: the mean TEWL from perilesional normal skin | 0 | {"evidence_spans": [{"end": 9311, "start": 9187, "text": "etween groups A and B (p=0.0359) (Fig. 3). And no significant difference was observed in the mean TEWL from perilesional nor"}], "id": "12685", "pmcid": "3505775", "prompt_id": "12685", "split_group_id": "3505775", "votes": {"0": 2}} |
Background
Several previous studies have suggested the improvement of atopic dermatitis (AD) in response to special fabrics. In particular, beneficial effects have been reported, following the use of anion textiles.
Objective
The purpose of this study is to evaluate the effectiveness and safety of an anion textile... | Intervention: anion textile
Comparator: pure cotton
Outcome: mean SCH for eczematous lesions | 0 | {"evidence_spans": [{"end": 9949, "start": 9820, "text": "ereas that in group B was not (p=0.0510). In addition, no significant difference was seen in the mean SCH for eczematous lesions "}, {"end": 9939, "start": 9832, "text": "n group B was not (p=0.0510). In addition, no significant difference was seen in the mean S... |
Background
Several previous studies have suggested the improvement of atopic dermatitis (AD) in response to special fabrics. In particular, beneficial effects have been reported, following the use of anion textiles.
Objective
The purpose of this study is to evaluate the effectiveness and safety of an anion textile... | Intervention: anion textile
Comparator: pure cotton
Outcome: The mean skin erythema in eczematous lesions on the flexor surface of the forearm | -1 | {"evidence_spans": [{"end": 10368, "start": 10180, "text": "se in the mean SCH values for both groups.\r\nThe mean skin erythema in eczematous lesions on the flexor surface of the forearm in group A decreased significantly from 425.6\u00b175.8 to 379.6\u00b191"}, {"end": 10604, "start": 10180, "text": "se in the mean S... |
Background
Defining optimal routes for induction of mucosal immunity represents an important research priority for the HIV-1 vaccine field. In particular, it remains unclear whether mucosal routes of immunization can improve mucosal immune responses.
Methods
In this randomized two center phase I clinical trial we ... | Intervention: HIV-1 Clade C CN54gp140 envelope glycoprotein vaccine administered by intramuscular (IM) route
Comparator: HIV-1 Clade C CN54gp140 envelope glycoprotein vaccine administered by intranasal (IN) or intravaginal (IVAG) route
Outcome: systemic and mucosal antibodies | 1 | {"evidence_spans": [{"end": 917, "start": 757, "text": "sults\r\nThree IM immunizations of CN54 gp140 at either 20 or 100 \u03bcg elicited significantly greater systemic and mucosal antibodies than either IN or IVAG immuniz"}], "id": "12688", "pmcid": "4861263", "prompt_id": "12688", "split_group_id": "4861263", "votes... |
AIM:
The present study aims to assess the therapeutic effect of the combination of topical ozone and steroid therapy in comparison to topical ozone alone versus topical steroid as a control in the management of atrophic - erosive oral lichen planus (OLP).
METHODS:
Sixty-six patients are having atrophic-erosive OLP... | Intervention: combination of topical steroids and ozone
Comparator: topical corticosteroids alone or ozone alone
Outcome: percentage of change of sign scores | 1 | {"evidence_spans": [{"end": 825, "start": 666, "text": "ULTS:\r\nThe results revealed that the greatest significant percentage of change and subsequent improvement in pain and sign scores were recorded in the combined"}, {"end": 13728, "start": 13482, "text": "\r\n2\r\n2\r\n3\r\n3\r\n3\r\n2\r\n1\r\nMin\r\n3\r\n3\r\n2\r... |
AIM:
The present study aims to assess the therapeutic effect of the combination of topical ozone and steroid therapy in comparison to topical ozone alone versus topical steroid as a control in the management of atrophic - erosive oral lichen planus (OLP).
METHODS:
Sixty-six patients are having atrophic-erosive OLP... | Intervention: combination of topical steroids and ozone
Comparator: ozone alone
Outcome: percentage of change of pain scores | 1 | {"evidence_spans": [{"end": 13728, "start": 13482, "text": "\r\n2\r\n2\r\n3\r\n3\r\n3\r\n2\r\n1\r\nMin\r\n3\r\n3\r\n2\r\n1\r\n0\r\n2\r\n2\r\n1\r\n1\r\n0\r\nMax\r\n5\r\n4\r\n3\r\n3\r\n3\r\n4\r\n3\r\n3\r\n2\r\n1\r\nMean rank\r\n4.9\r\n4.1\r\n2.5\r\n2\r\n1.5\r\n4.6\r\n4\r\n3.3\r\n2\r\n1.1\r\nP value\r\n\r\nChi square = 11... |
Background
Skin is a complete and independent melatoninergic system. At the skin level, melatonin (Mel) acts as a relevant antioxidant and cytoprotective substance. Topical application of Mel is considered meaningful, since it can easily penetrate the stratum corneum. Exogenous Mel can be expected to represent a poten... | Intervention: Day and night creams containing Mel, carried in lipospheres (Melatosphere™) on one half of the face
Comparator: Not treated another half of the face
Outcome: Skin dryness score | -1 | {"evidence_spans": [{"end": 8781, "start": 8610, "text": "the side treated with Mel creams. Skin dryness score was significantly lower in the active-treated side in comparison with the non-treated side (p=0.01; Mann\u2013Whitney U tes"}], "id": "12691", "pmcid": "5788993", "prompt_id": "12691", "split_group_id": "57889... |
Background
Skin is a complete and independent melatoninergic system. At the skin level, melatonin (Mel) acts as a relevant antioxidant and cytoprotective substance. Topical application of Mel is considered meaningful, since it can easily penetrate the stratum corneum. Exogenous Mel can be expected to represent a poten... | Intervention: Day and night creams containing Mel, carried in lipospheres (Melatosphere™) on one half of the face
Comparator: Not treated another half of the face
Outcome: Skin tonicity (resistance to traction, resistance to pinching and recovery after pinching) | 1 | {"evidence_spans": [{"end": 9025, "start": 8782, "text": "; 1.5\u00b10.4 vs 3.5\u00b10.6; Figure 1A). Skin tonicity (resistance to traction, resistance to pinching and recovery after pinching) significantly improved by 33% in comparison with the baseline value on the side treated with Mel creams only (from 3.0"}], "id"... |
Background
Skin is a complete and independent melatoninergic system. At the skin level, melatonin (Mel) acts as a relevant antioxidant and cytoprotective substance. Topical application of Mel is considered meaningful, since it can easily penetrate the stratum corneum. Exogenous Mel can be expected to represent a poten... | Intervention: Day and night creams containing Mel, carried in lipospheres (Melatosphere™) on one half of the face
Comparator: Not treated another half of the face
Outcome: Crow’s feet photographic severity score | -1 | {"evidence_spans": [{"end": 9235, "start": 9026, "text": "0.5 to 2.1\u00b10.4; Figure 1B and C). Crow\u2019s feet photographic severity score was reduced significantly (p=0.05) by \u221215% with the creams in comparison with both baseline value (2.3\u00b10.2 vs. 2.7\u00b10.3) and value of th"}], "id": "12693", "pmcid":... |
Background
Skin is a complete and independent melatoninergic system. At the skin level, melatonin (Mel) acts as a relevant antioxidant and cytoprotective substance. Topical application of Mel is considered meaningful, since it can easily penetrate the stratum corneum. Exogenous Mel can be expected to represent a poten... | Intervention: Day and night creams containing Mel, carried in lipospheres (Melatosphere™) on one half of the face
Comparator: Not treated another half of the face
Outcome: Surface microrelief photographic score | -1 | {"evidence_spans": [{"end": 1850, "start": 1677, "text": "3 months. At the end of the study, surface microrelief (\u221226.5%), skin profilometry (\u221213%), skin tonicity (+30%) and skin dryness (\u221259.5%) significantly improved with active "}, {"end": 9513, "start": 9236, "text": " non-treated side after 3 months... |
Background
Prostatic acid phosphatase (PAP) is a prostate tumor antigen, and the target of the only FDA-approved anti-tumor vaccine, sipuleucel-T. We have previously reported in two clinical trials that a DNA vaccine encoding PAP (pTVG-HP) could elicit PAP-specific, Th1-biased T cells in patients with PSA-recurrent pr... | Intervention: sipuleucel-T alone followed by intradermal immunization with pTVG-HP DNA vaccine
Comparator: sipuleucel-T alone
Outcome: Th1-biased PAP-specific T-cell responses | 0 | {"evidence_spans": [{"end": 1139, "start": 1006, "text": "erved. Th1-biased PAP-specific T-cell responses were detected in 11/18 individuals, and were not statistically different between stud"}], "id": "12696", "pmcid": "5850960", "prompt_id": "12696", "split_group_id": "5850960", "votes": {"0": 2}} |
Background
Prostatic acid phosphatase (PAP) is a prostate tumor antigen, and the target of the only FDA-approved anti-tumor vaccine, sipuleucel-T. We have previously reported in two clinical trials that a DNA vaccine encoding PAP (pTVG-HP) could elicit PAP-specific, Th1-biased T cells in patients with PSA-recurrent pr... | Intervention: sipuleucel-T alone followed by intradermal immunization with pTVG-HP DNA vaccine
Comparator: sipuleucel-T alone
Outcome: overall survival | 0 | {"evidence_spans": [{"end": 25542, "start": 25257, "text": "line, however then remained on trial without progression until month 9 and 12, respectively, at which point radiographic progression beyond month 3 was detected. All other patients with evidence of progression at month 3 had evidence of further progression by ... |
Background
Prostatic acid phosphatase (PAP) is a prostate tumor antigen, and the target of the only FDA-approved anti-tumor vaccine, sipuleucel-T. We have previously reported in two clinical trials that a DNA vaccine encoding PAP (pTVG-HP) could elicit PAP-specific, Th1-biased T cells in patients with PSA-recurrent pr... | Intervention: sipuleucel-T alone followed by intradermal immunization with pTVG-HP DNA vaccine
Comparator: sipuleucel-T alone
Outcome: PSA doubling time | 0 | {"evidence_spans": [{"end": 26030, "start": 25888, "text": "spect to study arm. PSA doubling times were calculated from PSA values obtained up to 6\u00a0months prior to treatment and up to 6\u00a0months from day "}, {"end": 30752, "start": 30632, "text": "us studies using sipuleucel-T in terms of time to progression. N... |
Background
Prostatic acid phosphatase (PAP) is a prostate tumor antigen, and the target of the only FDA-approved anti-tumor vaccine, sipuleucel-T. We have previously reported in two clinical trials that a DNA vaccine encoding PAP (pTVG-HP) could elicit PAP-specific, Th1-biased T cells in patients with PSA-recurrent pr... | Intervention: sipuleucel-T alone followed by intradermal immunization with pTVG-HP DNA vaccine
Comparator: sipuleucel-T alone
Outcome: median time to radiographic progression | 0 | {"evidence_spans": [{"end": 1352, "start": 1251, "text": "tions. Median time to progression was less than 6\u00a0months and not statistically different between stud"}, {"end": 24868, "start": 24644, "text": "time to radiographic progression, which was approximately 12\u00a0weeks [1, 18]. In order to account for this an... |
Background
The prognosis of patients bearing high grade glioma remains dismal. Epidermal Growth Factor Receptor (EGFR) is well validated as a primary contributor of glioma initiation and progression. Nimotuzumab is a humanized monoclonal antibody that recognizes the EGFR extracellular domain and reaches Central Nervou... | Intervention: radiotherapy plus nimotuzumab
Comparator: placebo
Outcome: the mean and median survival time | 1 | {"evidence_spans": [{"end": 1674, "start": 1533, "text": "icity. The mean and median survival time for subjects treated with nimotuzumab was 31.06 and 17.76 vs. 21.07 and 12.63 months for the control"}], "id": "12700", "pmcid": "3691625", "prompt_id": "12700", "split_group_id": "3691625", "votes": {"1": 1}} |
Background
The prognosis of patients bearing high grade glioma remains dismal. Epidermal Growth Factor Receptor (EGFR) is well validated as a primary contributor of glioma initiation and progression. Nimotuzumab is a humanized monoclonal antibody that recognizes the EGFR extracellular domain and reaches Central Nervou... | Intervention: radiotherapy plus nimotuzumab
Comparator: placebo
Outcome: mean and median overall survival in glioblastoma multiforme (GBM) patients | 1 | {"evidence_spans": [{"end": 16023, "start": 15834, "text": "mean and median survival time was 41.29 and 44.56 months, if they received nimotuzumab vs. 29.67 and 17.56 months for the control patients (Weibull statistics, p\u2009=\u20090.311). For the GBM patie"}], "id": "12701", "pmcid": "3691625", "prompt_id": "12701",... |
Background
The global burden of the major vascular diseases is projected to rise and to remain the dominant non-communicable disease cluster well into the twenty first century. The Department of Health in England has developed the NHS Health Check service as a policy initiative to reduce population vascular disease ri... | Intervention: NHS Health Check service plus additional lifestyle support in Stoke
Comparator: NHS Health Check service only
Outcome: Average population CVD risk | 0 | {"evidence_spans": [{"end": 1689, "start": 1427, "text": "sults\r\nAverage population CVD risk decreased from 32.9% to 29.4% (p <0.001) in the NHS Health Check only group and from 31.9% to 29.2% (p <0.001) in the NHS Health Check plus additional lifestyle support group. There was no significant difference between the t... |
Background
The global burden of the major vascular diseases is projected to rise and to remain the dominant non-communicable disease cluster well into the twenty first century. The Department of Health in England has developed the NHS Health Check service as a policy initiative to reduce population vascular disease ri... | Intervention: NHS Health Check service plus additional lifestyle support in Stoke
Comparator: NHS Health Check service only
Outcome: Prevalence of central obesity | -1 | {"evidence_spans": [{"end": 1997, "start": 1836, "text": "roups. Prevalence of central obesity was reduced significantly (p <0.01) in the group receiving additional lifestyle support but not in the NHS Health Check only"}], "id": "12703", "pmcid": "3524756", "prompt_id": "12703", "split_group_id": "3524756", "votes": {... |
Introduction
Correct inhaler technique and device preference are positively correlated with improved adherence and clinical outcomes. This study was designed to investigate inhaler technique mastery and device preference for three different dry powder inhalers, Spiromax, Easyhaler and Turbuhaler.
Methods
This was ... | Intervention: Spiromax
Comparator: Easyhaler and Turbuhaler
Outcome: level of device mastery | 1 | {"evidence_spans": [{"end": 13323, "start": 13046, "text": "r and Spiromax vs Turbuhaler); table 1). Similarly, in step 1, Spiromax was associated with a greater level of device mastery compared with Easyhaler or Turbuhaler; 37.5% of participants were able to use Spiromax with no errors in step 1 (intuitive use) compar... |
Introduction
Correct inhaler technique and device preference are positively correlated with improved adherence and clinical outcomes. This study was designed to investigate inhaler technique mastery and device preference for three different dry powder inhalers, Spiromax, Easyhaler and Turbuhaler.
Methods
This was ... | Intervention: Spiromax
Comparator: Easyhaler and Turbuhaler
Outcome: ‘overall ease of use’, ‘quality of PIL instructions’, ‘preparing the dose’, ‘clarity of dose counter’ | 1 | {"evidence_spans": [{"end": 17845, "start": 17452, "text": "participants and 11.8% indicated that they would prefer Turbuhaler if prescribed an inhaler.\r\nParticipants were also asked to rate their satisfaction with five features for the three devices: \u2018overall ease of use\u2019, \u2018quality of PIL instructions... |
Introduction
Correct inhaler technique and device preference are positively correlated with improved adherence and clinical outcomes. This study was designed to investigate inhaler technique mastery and device preference for three different dry powder inhalers, Spiromax, Easyhaler and Turbuhaler.
Methods
This was ... | Intervention: Spiromax
Comparator: Easyhaler and Turbuhaler
Outcome: ‘inhaling procedure’ | 0 | {"evidence_spans": [{"end": 17954, "start": 17846, "text": "gnificantly higher compared with both Easyhaler and Turbuhaler (p<0.001 for all comparisons). The difference"}], "id": "12707", "pmcid": "4809147", "prompt_id": "12707", "split_group_id": "4809147", "votes": {"0": 1}} |
Introduction
Correct inhaler technique and device preference are positively correlated with improved adherence and clinical outcomes. This study was designed to investigate inhaler technique mastery and device preference for three different dry powder inhalers, Spiromax, Easyhaler and Turbuhaler.
Methods
This was ... | Intervention: Turbuhaler
Comparator: Easyhaler
Outcome: ‘quality of PIL instructions’ | 1 | {"evidence_spans": [{"end": 18059, "start": 17955, "text": "was not significant for satisfaction with the \u2018inhaling procedure\u2019 between the three devices. Turbuhaler"}], "id": "12708", "pmcid": "4809147", "prompt_id": "12708", "split_group_id": "4809147", "votes": {"1": 2}} |
Background
Consumption of moderate amounts of animal-derived protein has been shown to differently influence skeletal muscle hypertrophy during resistance training when compared with nitrogenous and isoenergetic amounts of plant-based protein administered in small to moderate doses. Therefore, the purpose of the study... | Intervention: 48 g of rice protein isolate
Comparator: 48 g of whey protein isolate
Outcome: psychometric scores of perceived recovery, soreness, or readiness to train | 0 | {"evidence_spans": [{"end": 1659, "start": 1531, "text": "sults\r\nNo detectable differences were present in psychometric scores of perceived recovery, soreness, or readiness to train (p\u2009>"}], "id": "12711", "pmcid": "3698202", "prompt_id": "12711", "split_group_id": "3698202", "votes": {"0": 2}} |
Background
Consumption of moderate amounts of animal-derived protein has been shown to differently influence skeletal muscle hypertrophy during resistance training when compared with nitrogenous and isoenergetic amounts of plant-based protein administered in small to moderate doses. Therefore, the purpose of the study... | Intervention: 48g of rice protein isolate
Comparator: 48g of whey protein isolate
Outcome: lean body mass | 0 | {"evidence_spans": [{"end": 15389, "start": 15075, "text": "n x time effects for perceived readiness to train, indicating that the subject\u2019s perceived readiness had recovered within 48\u00a0hours.\r\n\r\nPhase 2\r\nThere was a significant time effect (p <0.01) for lean body mass, which increased in both the rice (... |
Background
Consumption of moderate amounts of animal-derived protein has been shown to differently influence skeletal muscle hypertrophy during resistance training when compared with nitrogenous and isoenergetic amounts of plant-based protein administered in small to moderate doses. Therefore, the purpose of the study... | Intervention: 48g of rice protein isolate
Comparator: 48g of whey protein isolate
Outcome: body fat | 0 | {"evidence_spans": [{"end": 15732, "start": 15391, "text": "nd whey protein (59.6\u2009\u00b1\u20095.2 to 61.9\u2009\u00b1\u20094.5 to 62.8\u2009\u00b1\u20095.2\u00a0kg) conditions, with no differences between conditions (no condition X time effect). There was a significant time effect for body fat (p\u2009<\u20090.05)... |
Background
Consumption of moderate amounts of animal-derived protein has been shown to differently influence skeletal muscle hypertrophy during resistance training when compared with nitrogenous and isoenergetic amounts of plant-based protein administered in small to moderate doses. Therefore, the purpose of the study... | Intervention: 48g of rice protein isolate
Comparator: 48g of whey protein isolate
Outcome: quadriceps and biceps thickness | 0 | {"evidence_spans": [{"end": 16172, "start": 15733, "text": "15.6\u2009\u00b1\u20094.9\u00a0kg in the whey protein condition, from pre to post training, with no differences between conditions (no condition X time effect). There was a significant time effect for quadriceps and biceps thickness (p\u2009<\u20090.05), which... |
Background
Consumption of moderate amounts of animal-derived protein has been shown to differently influence skeletal muscle hypertrophy during resistance training when compared with nitrogenous and isoenergetic amounts of plant-based protein administered in small to moderate doses. Therefore, the purpose of the study... | Intervention: 48g of rice protein isolate
Comparator: 48g of whey protein isolate
Outcome: 1-RM bench press strength | 0 | {"evidence_spans": [{"end": 16740, "start": 16439, "text": "ness and (D) Quadriceps muscle thickness.\u2009* Indicates significantly different from baseline. # Indicates significantly different from week 4.\r\nThere was a significant time effect (p\u2009<\u20090.01) for 1-RM bench press strength, which increased from b... |
Background
Few trials have evaluated the effectiveness of psychological treatment in improving depression by the end of pregnancy. This is the first pilot randomised controlled trial (RCT) of individual cognitive behavioural therapy (CBT) looking at treating depression by the end of pregnancy. Our aim was to assess th... | Intervention: individual cognitive behavioural therapy (CBT) with usual care
Comparator: usual care only
Outcome: Clinical Interview Schedule – revised (CIS-R) score | -1 | {"evidence_spans": [{"end": 26991, "start": 26851, "text": "story of depression (yes, no).\r\n*High scores reflect better quality of life.\r\n** Higher scores reflect greater cognitive awareness.\r\n\r\nConti"}], "id": "12716", "pmcid": "3666914", "prompt_id": "12716", "split_group_id": "3666914", "votes": {"-1": 1}} |
Objective:
Laparoscopic surgery is associated with reduced surgical stress response, lesser post- operative immune function, and consequent early recovery compared with conventional open surgery. There is a lack of evidence regarding the inflammatory stress response with the use of different energy devices. The presen... | Intervention: bipolar and ultrasonic energy (Thunderbeat), ultrasonic (Harmonic)
Comparator: electrothermal bipolar vessel sealing system (Ligasure)
Outcome: serum IL-6 levels | -1 | {"evidence_spans": [{"end": 1491, "start": 1384, "text": "ints, there was a significantly greater increase in serum IL-6 levels in the Ligasure group at 24 hours (p="}, {"end": 10711, "start": 10555, "text": "ken at various time points. There was a significantly higher increase in serum IL-6 levels in the Ligasure grou... |
Objective:
Laparoscopic surgery is associated with reduced surgical stress response, lesser post- operative immune function, and consequent early recovery compared with conventional open surgery. There is a lack of evidence regarding the inflammatory stress response with the use of different energy devices. The presen... | Intervention: bipolar and ultrasonic energy (Thunderbeat), ultrasonic (Harmonic)
Comparator: electrothermal bipolar vessel sealing system (Ligasure)
Outcome: TNF-α, RANTES, MIP-1 α, and MIP-1 β levels | 0 | {"evidence_spans": [{"end": 10955, "start": 10787, "text": "mage in the Ligasure group. However, there was no significant difference between the three groups in terms of inflammatory response as seen in levels of TNF-\u03b1, RANTES, "}, {"end": 11026, "start": 10796, "text": "he Ligasure group. However, there was no si... |
Objective:
Laparoscopic surgery is associated with reduced surgical stress response, lesser post- operative immune function, and consequent early recovery compared with conventional open surgery. There is a lack of evidence regarding the inflammatory stress response with the use of different energy devices. The presen... | Intervention: bipolar and ultrasonic energy (Thunderbeat), ultrasonic (Harmonic)
Comparator: electrothermal bipolar vessel sealing system (Ligasure)
Outcome: GI activity | 0 | {"evidence_spans": [{"end": 11484, "start": 11302, "text": "cal post-operative recovery. No significant difference was observed between the three groups in terms of return of GI activity at 6 hours [group 1: 17 (85%) vs. group 2: 18 (90%) vs."}, {"end": 11650, "start": 11302, "text": "cal post-operative recovery. No si... |
BACKGROUND:
Mobile health has the potential to revolutionize the role of educators by empowering nurses to take more responsibility for their own learning. Hence, this study was designed to examine the effect of mobile health method to emergency nurses’ knowledge about Emergency Severity Index triage.
MATERIALS AND... | Intervention: electronic group
Comparator: workshop group
Outcome: mean total age, working experience, and working hours of the nurses | 0 | {"evidence_spans": [{"end": 10955, "start": 10700, "text": "ses participated in the study\r\nIndependent t-test showed that there was no significant difference in mean total age (P = 0.23), working experience (P = 0.12), and working hours of the nurses (P = 0.41), before the study between the two groups that meant t"},... |
BACKGROUND:
Mobile health has the potential to revolutionize the role of educators by empowering nurses to take more responsibility for their own learning. Hence, this study was designed to examine the effect of mobile health method to emergency nurses’ knowledge about Emergency Severity Index triage.
MATERIALS AND... | Intervention: electronic group
Comparator: workshop group
Outcome: knowledge’ scores | 1 | {"evidence_spans": [{"end": 11469, "start": 11325, "text": "after intervention in two groups\r\nIn addition to these changes, knowledge\u2019 scores in both groups showed the highest increase in electronic (78%)"}], "id": "12723", "pmcid": "5791430", "prompt_id": "12723", "split_group_id": "5791430", "votes": {"1": 1}} |
Short-term increases in ambient air pollution have been associated with an increased incidence of acute cardiac events. We assessed the effect of inhalation exposure to concentrated ambient particles (CAPs) on myocardial ischemia in a canine model of coronary artery occlusion. Six mongrel dogs underwent thoracotomy for... | Intervention: breathe CAPs on the second exposure day
Comparator: filtered air at other times
Outcome: occlusion-induced peak ST-segment elevation | 1 | {"evidence_spans": [{"end": 1261, "start": 1027, "text": "Exposure to CAPs (median, 285.7; range, 161.3-957.3 microg/m3) significantly (p = 0.007) enhanced occlusion-induced peak ST-segment elevation in precordial leads V4 (9.4 +/- 1.7 vs. 6.2 +/- 0.9 mm, CAPs vs. filtered air, respectively)"}, {"end": 1302, "start": 1... |
Background
Hypertension and dyslipidemia are major risk factors of cardiovascular disease (CVD) events. The objective of this study was to evaluate the efficacy and safety of the co-administration of fimasartan and rosuvastatin in patients with hypertension and hypercholesterolemia.
Methods
We conducted a randomiz... | Intervention: co-administration of fimasartan 120 mg/rosuvastatin 20 mg (FMS/RSV),
Comparator: rosuvastatin 20 mg (RSV) alone,
Outcome: reductions in sitting systolic (siSBP) and diastolic (siDBP) blood pressures | -1 | {"evidence_spans": [{"end": 973, "start": 764, "text": "alyzed. After 8\u00a0weeks of treatment, the FMS/RSV treatment group showed greater reductions in sitting systolic (siSBP) and diastolic (siDBP) blood pressures than those in the group receiving RSV alone (both p\u2009<"}, {"end": 20383, "start": 20211, "text": "g... |
Background
Hypertension and dyslipidemia are major risk factors of cardiovascular disease (CVD) events. The objective of this study was to evaluate the efficacy and safety of the co-administration of fimasartan and rosuvastatin in patients with hypertension and hypercholesterolemia.
Methods
We conducted a randomiz... | Intervention: co-administration of fimasartan 120mg/rosuvastatin 20mg (FMS/RSV),
Comparator: fimasartan 120 mg (FMS) alone
Outcome: reductions in sitting systolic (siSBP) and diastolic (siDBP) blood pressures | 0 | {"evidence_spans": [{"end": 1117, "start": 973, "text": "\u20090.001). Reductions in siSBP and siDBP were not significantly different between the FMS/RSV and FMS alone groups (p\u2009=\u20090.500 and p\u2009=\u20090.734, respe"}, {"end": 1118, "start": 974, "text": "0.001). Reductions in siSBP and siDBP were not signif... |
Background
Hypertension and dyslipidemia are major risk factors of cardiovascular disease (CVD) events. The objective of this study was to evaluate the efficacy and safety of the co-administration of fimasartan and rosuvastatin in patients with hypertension and hypercholesterolemia.
Methods
We conducted a randomiz... | Intervention: co-administration of fimasartan 120mg/rosuvastatin 20mg (FMS/RSV),
Comparator: fimasartan 120 mg (FMS) alone
Outcome: low-density lipoprotein cholesterol (LDL-C) level | -1 | {"evidence_spans": [{"end": 1330, "start": 1118, "text": "tively). After 8\u00a0weeks of treatment, FMS/RSV treatment showed greater efficacy in percentage reduction of low-density lipoprotein cholesterol (LDL-C) level from baseline than that shown by FMS alone treatment (p\u2009"}], "id": "12727", "pmcid": "5217661", ... |
Cognitive rehabilitation programs have demonstrated efficacy in improving cognitive functions in Parkinson’s disease (PD), but little is known about cerebral changes associated with an integrative cognitive rehabilitation in PD. To assess structural and functional cerebral changes in PD patients, after attending a thre... | Intervention: REHACOP group (cognitive rehabilitation)
Comparator: control group (occupational therapy)
Outcome: connectivity between the left dorsal posterior cingulate cortex Brodmann Area (BA31) and the left piriform cortex (BA27) | -1 | {"evidence_spans": [{"end": 24644, "start": 24348, "text": "thickness (left and right) were found between groups. Longitudinal analysis showed no significant structural changes within or between groups at post-treatment.\r\n\r\nResting-state fMRI\r\nBaseline differences in brain activation in resting-state fMRI were fo... |
Objective
This 1-year study aimed to assess low-dose budesonide therapy for maintenance of clinical remission in patients with collagenous colitis.
Design
A prospective, randomised, placebo-controlled study beginning with an 8-week open-label induction phase in which patients with histologically confirmed active c... | Intervention: budesonide (mean dose 4.5 mg/day; Budenofalk 3 mg capsules, two or one capsule on alternate days)
Comparator: placebo
Outcome: The maintenance of clinical remission at 1 year | 1 | {"evidence_spans": [{"end": 1148, "start": 903, "text": "ays)). The maintenance of clinical remission at 1\u2005year was achieved by 61.4% (27/44 patients) in the budesonide group versus 16.7% (8/48 patients) receiving placebo (treatment difference 44.5% in favour of budesonide; 95% CI (26.9% to 62.7%), p<"}], "id": "1... |
Background:
Pelvic organ prolapse is the growing health issue related to women of the reproductive and postmenopausal age group in India and across the globe. Treatment option for pelvic organ prolapse includes both surgical and non-surgical intervention. The development of pelvic organ prolapse is an indication for m... | Intervention: Mulabandha yoga therapy + conventional treatment
Comparator: only on conventional treatment
Outcome: chief complaints like perennial pain, P/V discharge, Perineal muscle laxity and Feeling of something coming out P/V | -1 | {"evidence_spans": [{"end": 1538, "start": 1297, "text": "weeks. Results At the end of 12 weeks, Post-study comparison between the two groups showed a significant improvement in chief complaints like perennial pain, P/V discharge, Perineal muscle laxity and Feeling of something coming out P/V (P < "}], "id": "12739", "... |
Purpose
The present study has two aims; firstly, it attempts to verify the presence of oxidative stress by estimating the reactive oxygen species (ROS) levels in periodontal pockets ≥5 mm as compared to controls. The second aim is to evaluate the effect of lycopene as a locally delivered antioxidant gel on periodontal... | Intervention: sham group, only scaling and root planing (SRP) was done; placebo group, local delivery of placebo gel after SRP;
Comparator: lycopene group, local delivery of lycopene gel after SRP
Outcome: 8-OHdG levels | -1 | {"evidence_spans": [{"end": 1242, "start": 1020, "text": "sults\r\nThe gel, when delivered to the sites with oxidative stress, was effective in increasing clinical attachment and in reducing gingival inflammation, probing depth, and 8-OHdG levels as compared to the placebo and sham"}, {"end": 14454, "start": 14296, "te... |
Purpose
The present study has two aims; firstly, it attempts to verify the presence of oxidative stress by estimating the reactive oxygen species (ROS) levels in periodontal pockets ≥5 mm as compared to controls. The second aim is to evaluate the effect of lycopene as a locally delivered antioxidant gel on periodontal... | Intervention: sham group, only scaling and root planing (SRP) was done; placebo group, local delivery of placebo gel after SRP;
Comparator: lycopene group, local delivery of lycopene gel after SRP
Outcome: modified gingival index (MGI) scores | 1 | {"evidence_spans": [{"end": 16701, "start": 16472, "text": "r weeks and twelve weeks when compared to the other two groups. Finally, with regard to the MGI, a significant reduction in the mean gingival scores was seen in the lycopene group at the end of two weeks (P<0.01) and a highly sig"}], "id": "12742", "pmcid": "3... |
Introduction
Candida prophylaxis in ICU is still a matter of debate. Oral chemoprophylaxis has been advocated to reduce the incidence of Candida colonisation and infection.
Methods
We performed a randomised trial studying a single drug (nystatin) versus control in surgical/trauma ICU patients. Multiple-site testin... | Intervention: single drug (nystatin)
Comparator: control
Outcome: proportion of positive stomach samples | -1 | {"evidence_spans": [{"end": 13142, "start": 12893, "text": "e interquartile range (borders of the box). Data in parentheses are the number of patients in each of the two study groups over time. *P <0.05.\r\nDuring hospitalisation in the ICU the proportion of positive stomach samples significantly decreased in "}], "id"... |
Background
Gadoxetic acid and gadopentetate dimeglumine are gadolinium-based contrast agents (GBCAs) with an established role in HCC detection and characterization.
Purpose
To compare gadopentetate dimeglumine and gadoxetic acid-enhanced magnetic resonance imaging (MRI) for image quality and hepatocellular carcino... | Intervention: gadopentetate dimeglumine
Comparator: gadoxetic acid
Outcome: image quality | 0 | {"evidence_spans": [{"end": 984, "start": 895, "text": "\nResults\r\nThere was no significant difference in image quality scores between both GBCAs "}, {"end": 17435, "start": 17155, "text": "sh-in/wash-out on dynamic postcontrast imaging.\r\n\r\nMRI findings\r\nImage quality and qualitative vessel enhancement\r\nNo si... |
Background
Gadoxetic acid and gadopentetate dimeglumine are gadolinium-based contrast agents (GBCAs) with an established role in HCC detection and characterization.
Purpose
To compare gadopentetate dimeglumine and gadoxetic acid-enhanced magnetic resonance imaging (MRI) for image quality and hepatocellular carcino... | Intervention: gadopentetate dimeglumine
Comparator: gadoxetic acid
Outcome: qualitative vascular enhancement | 0 | {"evidence_spans": [{"end": 17560, "start": 17436, "text": "er 1 and 15.0\u2009\u00b1\u20092.1 vs. 14.0\u2009\u00b1\u20092.3 for observer 2 for gadopentetate dimeglumine and gadoxetic acid, respectively). There was"}, {"end": 17561, "start": 17436, "text": "er 1 and 15.0\u2009\u00b1\u20092.1 vs. 14.0\u2009\u00b1\u20092... |
Background
Gadoxetic acid and gadopentetate dimeglumine are gadolinium-based contrast agents (GBCAs) with an established role in HCC detection and characterization.
Purpose
To compare gadopentetate dimeglumine and gadoxetic acid-enhanced magnetic resonance imaging (MRI) for image quality and hepatocellular carcino... | Intervention: gadopentetate dimeglumine
Comparator: gadoxetic acid
Outcome: qualitative vascular enhancement for hepatic veins | 1 | {"evidence_spans": [{"end": 17721, "start": 17561, "text": "no significant difference in qualitative vascular enhancement between gadopentetate dimeglumine and gadoxetic acid, with the exception of higher scores for hepa"}], "id": "12750", "pmcid": "4364400", "prompt_id": "12750", "split_group_id": "4364400", "votes": ... |
Background
Gadoxetic acid and gadopentetate dimeglumine are gadolinium-based contrast agents (GBCAs) with an established role in HCC detection and characterization.
Purpose
To compare gadopentetate dimeglumine and gadoxetic acid-enhanced magnetic resonance imaging (MRI) for image quality and hepatocellular carcino... | Intervention: gadopentetate dimeglumine
Comparator: gadoxetic acid
Outcome: lesion conspicuity CE T1W imaging dynamic phases | 0 | {"evidence_spans": [{"end": 18670, "start": 18524, "text": "V were similar for both GBCAs and for both observers (observer 1: 92.3 %, observer 2: 91.6%).\r\n\r\nHCC lesion conspicuity\r\nNo significant difference"}], "id": "12751", "pmcid": "4364400", "prompt_id": "12751", "split_group_id": "4364400", "votes": {"0": 2}... |
Background
Gadoxetic acid and gadopentetate dimeglumine are gadolinium-based contrast agents (GBCAs) with an established role in HCC detection and characterization.
Purpose
To compare gadopentetate dimeglumine and gadoxetic acid-enhanced magnetic resonance imaging (MRI) for image quality and hepatocellular carcino... | Intervention: gadopentetate dimeglumine
Comparator: gadoxetic acid
Outcome: lesion conspicuity score on AP1 | 1 | {"evidence_spans": [{"end": 18844, "start": 18524, "text": "V were similar for both GBCAs and for both observers (observer 1: 92.3 %, observer 2: 91.6%).\r\n\r\nHCC lesion conspicuity\r\nNo significant differences in lesion conspicuity were observed between gadopentetate dimeglumine and gadoxetic acid CE T1W imaging dy... |
Aim/hypothesis
To assess whether low-dose glucocorticoid treatment induces adverse metabolic effects, as is evident for high glucocorticoid doses.
Methods
In a randomised placebo-controlled double-blind (participants and the investigators who performed the studies and assessed the outcomes were blinded) dose–respo... | Intervention: prednisolone 7.5 mg once daily
Comparator: placebo
Outcome: Peripheral glucose uptake | 0 | {"evidence_spans": [{"end": 1289, "start": 1224, "text": "cebo). Peripheral glucose uptake was not reduced by prednisolone "}, {"end": 1354, "start": 1224, "text": "cebo). Peripheral glucose uptake was not reduced by prednisolone 7.5\u00a0mg, but was decreased by prednisolone 30\u00a0mg by 34\u2009\u00b1\u20096% (p\u20... |
Aim/hypothesis
To assess whether low-dose glucocorticoid treatment induces adverse metabolic effects, as is evident for high glucocorticoid doses.
Methods
In a randomised placebo-controlled double-blind (participants and the investigators who performed the studies and assessed the outcomes were blinded) dose–respo... | Intervention: prednisolone 30 mg once daily and prednisolone 7,5 mg once daily
Comparator: placebo
Outcome: lipolysis in the fasted state | 0 | {"evidence_spans": [{"end": 1460, "start": 1354, "text": ".0001). Compared with placebo, prednisolone treatment tended to decrease lipolysis in the fasted state (p\u2009"}], "id": "12755", "pmcid": "3131514", "prompt_id": "12755", "split_group_id": "3131514", "votes": {"0": 1}} |
Aim/hypothesis
To assess whether low-dose glucocorticoid treatment induces adverse metabolic effects, as is evident for high glucocorticoid doses.
Methods
In a randomised placebo-controlled double-blind (participants and the investigators who performed the studies and assessed the outcomes were blinded) dose–respo... | Intervention: prednisolone 30 mg once daily and prednisolone 7,5 mg once daily
Comparator: placebo
Outcome: insulin-mediated suppression of lipolysis | -1 | {"evidence_spans": [{"end": 1604, "start": 1355, "text": "0001). Compared with placebo, prednisolone treatment tended to decrease lipolysis in the fasted state (p\u2009=\u20090.062), but both prednisolone 7.5\u00a0mg and prednisolone 30\u00a0mg decreased insulin-mediated suppression of lipolysis by 11\u2009\u00b1\u2009... |
Aim/hypothesis
To assess whether low-dose glucocorticoid treatment induces adverse metabolic effects, as is evident for high glucocorticoid doses.
Methods
In a randomised placebo-controlled double-blind (participants and the investigators who performed the studies and assessed the outcomes were blinded) dose–respo... | Intervention: prednisolone 30 mg once daily and prednisolone 7,5 mg once daily
Comparator: placebo
Outcome: whole-body proteolysis during hyperinsulinaemia | 0 | {"evidence_spans": [{"end": 1763, "start": 1605, "text": "ively. Finally, prednisolone treatment increased whole-body proteolysis during hyperinsulinaemia, which tended to be driven by prednisolone 30\u00a0mg (5\u2009\u00b1\u20092%; p\u2009="}], "id": "12757", "pmcid": "3131514", "prompt_id": "12757", "split_group_id":... |
Abstract
Aims
To evaluate the effect of multifaceted interventions using the Achievable Benchmark of Care (ABC) method for improving the technical quality of diabetes care in primary care settings.
Methods
We conducted a 1‐year cluster randomized controlled trial in 22 regions divided into an intervention group (... | Intervention: Achievable Benchmark of Care (ABC) method
Comparator: control group (CG)
Outcome: quality‐of‐care score | 1 | {"evidence_spans": [{"end": 1166, "start": 817, "text": " 1.2%). The quality\u2010of\u2010care score in the CG changed from 50.2%\u2010point at baseline to 51%\u2010point at 12 months, whereas the IG score changed from 49.9%\u2010point to 69.6%\u2010point, with statistically significant differences between the two grou... |
Background
Pulsed electromagnetic field (PEMF) is reported to be an effective adjunct for the management of nonunion long-bone fractures. Most studies implement PEMF treatment after 6 months or longer of delayed union or nonunion following fracture treatment. Despite these variations in treatment, the early applicatio... | Intervention: Pulsed electromagnetic field (PEMF)
Comparator: sham treatment
Outcome: fracture union success rate | 0 | {"evidence_spans": [{"end": 1223, "start": 1028, "text": "sults\r\nPatients in the PEMF group showed a higher rate of union than those in the control group after the first three months of treatment, but this difference failed to achieve statistical signif"}, {"end": 11601, "start": 11405, "text": " with a success rate ... |
Background
Pulsed electromagnetic field (PEMF) is reported to be an effective adjunct for the management of nonunion long-bone fractures. Most studies implement PEMF treatment after 6 months or longer of delayed union or nonunion following fracture treatment. Despite these variations in treatment, the early applicatio... | Intervention: Pulsed electromagnetic field (PEMF)
Comparator: sham treatment
Outcome: the average lengths of treatment | 0 | {"evidence_spans": [{"end": 11930, "start": 11812, "text": " in 17 patients in each of the groups, who subsequently received extended PEMF or sham treatment. At the end of the st"}], "id": "12760", "pmcid": "3556314", "prompt_id": "12760", "split_group_id": "3556314", "votes": {"0": 1}} |
Background
Pulsed electromagnetic field (PEMF) is reported to be an effective adjunct for the management of nonunion long-bone fractures. Most studies implement PEMF treatment after 6 months or longer of delayed union or nonunion following fracture treatment. Despite these variations in treatment, the early applicatio... | Intervention: Pulsed electromagnetic field (PEMF)
Comparator: sham treatment
Outcome: The total times from operation | 0 | {"evidence_spans": [{"end": 12339, "start": 12193, "text": "roup 2 (P\u2009=\u20090.029, Table\u20091). The relative risk of fracture union was 1.61 (95% CI, 1.04 to 2.48). The total times from operation to the end of the"}], "id": "12761", "pmcid": "3556314", "prompt_id": "12761", "split_group_id": "3556314", "votes":... |
Introduction:
Mindfulness is about being aware of internal and external stimuli by witnessing the act in a nonjudgmental manner. Earlier researches suggest that positive affectivity (PA) is negatively related to negative affectivity, aggression, and counterproductive work behavior (CWB).
Aim:
The present study exa... | Intervention: Yoga group
Comparator: control group
Outcome: reduction in aggression | 1 | {"evidence_spans": [{"end": 1164, "start": 1085, "text": "aled that Yoga group showed statistically significant (P < 0.001) reduction in "}], "id": "12763", "pmcid": "5041384", "prompt_id": "12763", "split_group_id": "5041384", "votes": {"1": 1}} |
Introduction:
Mindfulness is about being aware of internal and external stimuli by witnessing the act in a nonjudgmental manner. Earlier researches suggest that positive affectivity (PA) is negatively related to negative affectivity, aggression, and counterproductive work behavior (CWB).
Aim:
The present study exa... | Intervention: Yoga group
Comparator: control group
Outcome: positive affectivity (PA) | 1 | {"evidence_spans": [{"end": 1246, "start": 1046, "text": "e groups. Postintervention results revealed that Yoga group showed statistically significant (P < 0.001) reduction in aggression and significant (P < 0.001) enhancement in PA in comparison to the cont"}, {"end": 1245, "start": 1084, "text": "ealed that Yoga grou... |
Aims
To perform a deterministic cost-utility analysis, from a 1-year societal perspective, of two treatment programs for stress urinary incontinence (SUI) without face-to-face contact: one Internet-based and one sent by post. The treatments were compared with each other and with no treatment.
Methods
We performed ... | Intervention: programs for stress urinary incontinence (SUI) without face-to-face contact: Internet-based one sent by post
Comparator: programs for stress urinary incontinence (SUI) without face-to-face contact: sent by post
Outcome: Quality of Life, Utility Weights, and QALYs | 0 | {"evidence_spans": [{"end": 17510, "start": 17411, "text": ".001) in the overall scores in the ICIQ-LUTSqol at 4 months (mean change Internet 4.8 [SD 6.1], Pos"}, {"end": 17735, "start": 17411, "text": ".001) in the overall scores in the ICIQ-LUTSqol at 4 months (mean change Internet 4.8 [SD 6.1], Postal 4.6 [SD 6.7]),... |
Introduction
There is important evidence on the beneficial effects of treatment of cardiovascular risk factors in terms of morbidity and mortality, but important challenges remain in motivating patients to adhere to their treatment regimen. This study aimed to describe the effectiveness of a quality improvement interv... | Intervention: advanced care group (ACG)
Comparator: usual care group (UCG)
Outcome: heart rate | 0 | {"evidence_spans": [{"end": 12598, "start": 12380, "text": "ively (P = 0.008 and P = 0.004, respectively).\r\nFurther, during the course of the study, no significant difference in heart rate was detected between the two groups and, after 6 months, there was no decrease in heart r"}, {"end": 12598, "start": 12389, "text... |
Introduction
There is important evidence on the beneficial effects of treatment of cardiovascular risk factors in terms of morbidity and mortality, but important challenges remain in motivating patients to adhere to their treatment regimen. This study aimed to describe the effectiveness of a quality improvement interv... | Intervention: advanced care group (ACG)
Comparator: usual care group (UCG)
Outcome: body weight | 0 | {"evidence_spans": [{"end": 10975, "start": 10843, "text": "d between the groups.\r\n\r\nLifestyle changes\r\nNo single patient in the UCG or ACG ceased smoking and no significant changes in body we"}, {"end": 11157, "start": 10977, "text": "ht were detected in either group (Table 2). After 6 months: the average weight... |
Background
Chronic kidney disease (CKD) is associated with elevations in serum phosphate, calcium–phosphorus product and bone-specific alkaline phosphatase (BAP), with attendant risks of cardiovascular and bone disorders. Active vitamin D can suppress parathyroid hormone (PTH), but may raise serum calcium and phosphat... | Intervention: paricalcitol (1 or 2 μg/day)
Comparator: placebo-
Outcome: serum phosphorus concentration | -1 | {"evidence_spans": [{"end": 12713, "start": 12482, "text": "aricalcitol 1 \u03bcg/day and 0.07 g for paricalcitol 2 \u03bcg/day (P values were not significant for all comparisons with placebo). Following treatment withdrawal, the serum phosphorus concentration decreased to below baseline in the paric"}], "id": "12768",... |
Background
Chronic kidney disease (CKD) is associated with elevations in serum phosphate, calcium–phosphorus product and bone-specific alkaline phosphatase (BAP), with attendant risks of cardiovascular and bone disorders. Active vitamin D can suppress parathyroid hormone (PTH), but may raise serum calcium and phosphat... | Intervention: paricalcitol (1 or 2 μg/day)
Comparator: placebo-
Outcome: calcium | 1 | {"evidence_spans": [{"end": 13556, "start": 13374, "text": "erum calcium concentration in the paricalcitol treatment groups from baseline to last on-treatment measurement (Figure\u00a01B and 3). Increases from baseline in serum calcium were observ"}, {"end": 13557, "start": 13374, "text": "erum calcium concentration in... |
Background
Chronic kidney disease (CKD) is associated with elevations in serum phosphate, calcium–phosphorus product and bone-specific alkaline phosphatase (BAP), with attendant risks of cardiovascular and bone disorders. Active vitamin D can suppress parathyroid hormone (PTH), but may raise serum calcium and phosphat... | Intervention: paricalcitol (1 or 2 μg/day)
Comparator: placebo-
Outcome: 24-h urinary calcium excretion | 1 | {"evidence_spans": [{"end": 14058, "start": 13782, "text": "rred in only three patients (3.2%) in the paricalcitol 2-\u03bcg/day group and one patient (1.1%) in the paricalcitol 1-\u03bcg/day group. Increases in 24-h urinary calcium excretion from baseline to last on-treatment assessment paralleled changes in serum cal... |
Background
Chronic kidney disease (CKD) is associated with elevations in serum phosphate, calcium–phosphorus product and bone-specific alkaline phosphatase (BAP), with attendant risks of cardiovascular and bone disorders. Active vitamin D can suppress parathyroid hormone (PTH), but may raise serum calcium and phosphat... | Intervention: paricalcitol (1 or 2 μg/day)
Comparator: placebo-
Outcome: intact PTH (iPTH) (parathyroid hormone) | -1 | {"evidence_spans": [{"end": 14910, "start": 14646, "text": "C. In placebo-treated patients, iPTH levels increased to 20.5 pg/mL at the end of treatment and 27.5 pg/mL at 60 days after treatment. In the active treatment groups, there was a dose-dependent reduction in iPTH, with a 26.9-pg/mL decrease in the 1-\u03bcg/day... |
Background
Elobixibat is a minimally absorbed ileal bile acid (BA) transporter (IBAT) inhibitor in development against chronic constipation (CC) and constipation-predominant Irritable Bowel Syndrome (IBS-C). CC is associated with an increased risk for cardiovascular disease and type2 diabetes mellitus. The objectives ... | Intervention: 2.5 mg or 5 mg elobixibat
Comparator: placebo
Outcome: LDL cholesterol | -1 | {"evidence_spans": [{"end": 1272, "start": 1198, "text": "sults\r\nIn the dyslipidemia study LDL cholesterol was reduced by 7.4\u00a0% (p\u2009="}, {"end": 14097, "start": 13835, "text": "\u00a0mg elobixibat treatment group \u2013 the primary end point of the study (Fig.\u00a02). No significant change was achieved for ... |
Background
Acute stress drives a ‘high-alert’ response in the immune system. Psychoactive drugs induce distinct stress hormone profiles, offering a sought-after opportunity to dissect the in vivo immunological effects of acute stress in humans.
Methods
3,4-methylenedioxymethamphetamine (MDMA), methylphenidate (MPH... | Intervention: 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxymethamphetamine (MDMA)+methylphenidate (MPH)
Comparator: placebo, MPH alone
Outcome: cortisol concentration | 1 | {"evidence_spans": [{"end": 11600, "start": 11400, "text": "inephrine at 2 hours (data not shown). The most striking difference between the drug conditions was an increase in cortisol concentration upon exposure to MDMA (p < 0.001) or MDMA/MPH (p < 0.0001) com"}], "id": "12773", "pmcid": "4689586", "prompt_id": "12773"... |
Background
Acute stress drives a ‘high-alert’ response in the immune system. Psychoactive drugs induce distinct stress hormone profiles, offering a sought-after opportunity to dissect the in vivo immunological effects of acute stress in humans.
Methods
3,4-methylenedioxymethamphetamine (MDMA), methylphenidate (MPH... | Intervention: 3,4-methylenedioxymethamphetamine (MDMA)+methylphenidate (MPH)
Comparator: MPH alone
Outcome: epinephrine concentrations | 1 | {"evidence_spans": [{"end": 763, "start": 684, "text": "sults\r\nMDMA/MPH > MDMA > MPH robustly induced an epinephrine-dominant stress re"}, {"end": 11921, "start": 11773, "text": "lood draws, all starting at 8 am [19]. The increase in epinephrine concentrations was higher in individuals exposed to MDMA/MPH (p < 0.0001... |
Objective
To assess the relief of migraine pain, especially in the acute phase, by comparing active treatment, ie, kinetic oscillation stimulation (KOS) in the nasal cavity, with placebo.
Background
Exploratory trials testing the efficacy of KOS on migraine patients indicated that this treatment could be a fast-ac... | Intervention: kinetic oscillation stimulation (KOS) in the nasal cavity
Comparator: placebo treatment
Outcome: pain scores | -1 | {"evidence_spans": [{"end": 1386, "start": 1024, "text": "\nResults\r\nPatients who received active treatment reported reduced pain, eg, average visual analog scale pain scores fell from 5.5 before treatment to 1.2 15 minutes after, while the corresponding scores for recipients of placebo fell from 4.9 to 3.9. The chan... |
Objective
To assess the relief of migraine pain, especially in the acute phase, by comparing active treatment, ie, kinetic oscillation stimulation (KOS) in the nasal cavity, with placebo.
Background
Exploratory trials testing the efficacy of KOS on migraine patients indicated that this treatment could be a fast-ac... | Intervention: kinetic oscillation stimulation (KOS) in the nasal cavity
Comparator: placebo treatment
Outcome: the proportion of headache days | 0 | {"evidence_spans": [{"end": 24090, "start": 23859, "text": " in the active group were pain-free at 15 minutes post-treatment compared with 2 out of 17 (12%) for the placebo group. End-point metrics for patients who reported data for both 2 and 24 hours post-treatment are presented in Table\u2009"}, {"end": 24091, "star... |
Objective
To assess the relief of migraine pain, especially in the acute phase, by comparing active treatment, ie, kinetic oscillation stimulation (KOS) in the nasal cavity, with placebo.
Background
Exploratory trials testing the efficacy of KOS on migraine patients indicated that this treatment could be a fast-ac... | Intervention: kinetic oscillation stimulation (KOS) in the nasal cavity
Comparator: placebo treatment
Outcome: The pain intensity and attack duration | 0 | {"evidence_spans": [{"end": 24274, "start": 24092, "text": "\r\nThe number of days during the 2 months of follow-up when patients experienced migraine pain fell slightly in the active group compared with the situation during the run-in period. "}], "id": "12777", "pmcid": "4312979", "prompt_id": "12777", "split_group_i... |
Aim
To prospectively evaluate the effects of vitamin D3 on disease activity and quality of life in ulcerative colitis (UC) patients with hypovitaminosis D.
Methods
The study was a prospective double-blinded, randomized trial conducted at Community Regional Medical Center, Fresno, CA from 2012–2013. Patients with U... | Intervention: 2,000 IU of oral vitamin D3
Comparator: 4,000 IU of oral vitamin D3
Outcome: vitamin D levels | 1 | {"evidence_spans": [{"end": 1284, "start": 1068, "text": "roups. However, the increase in vitamin D levels after 90 days of oral vitamin D3, in the 4,000 IU group was significantly higher 16.80\u00a0\u00b1\u00a09.15 (p\u00a0<\u00a00.001) compared to the 2,000 IU group of vitamin D 5.00\u00a0\u00b1\u00a03.12 (p\u00a0=\u... |
Aim
To prospectively evaluate the effects of vitamin D3 on disease activity and quality of life in ulcerative colitis (UC) patients with hypovitaminosis D.
Methods
The study was a prospective double-blinded, randomized trial conducted at Community Regional Medical Center, Fresno, CA from 2012–2013. Patients with U... | Intervention: 2,000 IU of oral vitamin D3
Comparator: 4,000 IU of oral vitamin D3
Outcome: Partial Mayo UC Score | 0 | {"evidence_spans": [{"end": 1881, "start": 1662, "text": "0.87). In the 2,000 IU of vitamin D3 group the mean decrease in the Partial Mayo UC Score was \u22120.5\u00a0\u00b1\u00a01.5 (p\u00a0=\u00a00.38) compared to \u22121.3\u00a0\u00b1\u00a02.9 (p\u00a0=\u00a00.19) in the 4,000 IU vitamin D3 group but this was not st... |
Background & objectives:
Hydroxyethyl starches (HES) 130/0.4 (Voluven®) and 130/0.42 (Venofundin®) impair coagulation less than older HES solutions with higher molecular weight and molar substitution. Thus, these may be used in high doses up to 50 ml/kg/day. The aim of this study was to investigate and compare the eff... | Intervention: Hydroxyethyl starches (HES) 130/0.4 (Voluven®)
Comparator: 130/0.42 (Venofundin®)
Outcome: reaction time, kinetic time, α-angle, maximum amplitude and coagulation index | 0 | {"evidence_spans": [{"end": 1016, "start": 854, "text": "lyzed. Measurements of reaction time, kinetic time, \u03b1-angle, maximum amplitude and coagulation index before and after colloid infusion did not differ between the "}], "id": "12780", "pmcid": "3510891", "prompt_id": "12780", "split_group_id": "3510891", "vote... |
Background
The effect of the addition of fotemustine and/or interferon (IFN) to standard therapy with dacarbazine alone in patients with advanced malignant melanoma was investigated in a multicenter, randomized 2x2 factorial design trial.
Methods
A total of 260 patients were randomly assigned to one of four treatm... | Intervention: (A) fotemustine and dacarbazine repeated on 3-week cycle; (B) same treatment as (A) plus IFN-α2b three times per week;
Comparator: (C) dacarbazine alone repeated on 3-week cycle; (D) same treatment as (C) plus IFN-α2b three times per week
Outcome: overall survival (OS) , progression-free survival | 0 | {"evidence_spans": [{"end": 945, "start": 687, "text": "sults\r\nAddition of fotemustine did not significantly improve overall survival (OS) (p=0.28) or progression-free survival (PFS) (p=0.55); Hazard ratio (HR) for OS was 0.93 (95% CI 0.71-1.21). Similarly, addition of IFN-\u03b12b did not improve OS (p=0.68) or PFS ... |
Background
Elobixibat is an oral treatment candidate for chronic constipation with a novel mechanism of action via inhibition of the ileal bile acid transporter. We performed this randomized, double-blind, placebo-controlled, dose-finding phase IIb study in Japanese patients with chronic constipation to determine the ... | Intervention: elobixibat (5, 10, or 15 mg)
Comparator: placebo
Outcome: frequency of spontaneous bowel movements | 1 | {"evidence_spans": [{"end": 1099, "start": 813, "text": "s set. In the 10- and 15-mg groups, frequency of spontaneous bowel movements (\u00b1standard deviation) were significantly higher than baseline (5.7\u00a0\u00b1\u00a04.2 and 5.6\u00a0\u00b1\u00a03.5\u00a0times per week, respectively, compared with 2.6\u00a0\u00b1... |
Background
Elobixibat is an oral treatment candidate for chronic constipation with a novel mechanism of action via inhibition of the ileal bile acid transporter. We performed this randomized, double-blind, placebo-controlled, dose-finding phase IIb study in Japanese patients with chronic constipation to determine the ... | Intervention: elobixibat (5, 10, or 15&nbsp;mg)
Comparator: placebo
Outcome: LDL cholesterol | -1 | {"evidence_spans": [{"end": 20812, "start": 20584, "text": ")\r\n\u00a0Nausea\r\n0 (0.0)\r\n1 (2.3)\r\n1 (2.6)\r\n0 (0.0)\r\n\u00a0Vomiting\r\n0 (0.0)\r\n0 (0.0)\r\n1 (2.6)\r\n0 (0.0)\r\n\r\n\r\nThere were no clinically significant changes in laboratory tests or vital signs between groups, with the exception of LDL cho... |
Background
Elobixibat is an oral treatment candidate for chronic constipation with a novel mechanism of action via inhibition of the ileal bile acid transporter. We performed this randomized, double-blind, placebo-controlled, dose-finding phase IIb study in Japanese patients with chronic constipation to determine the ... | Intervention: elobixibat (5, 10, or 15&amp;nbsp;mg)
Comparator: placebo
Outcome: HDL cholesterol | 0 | {"evidence_spans": [{"end": 21378, "start": 21311, "text": "03.7\u00a0\u00b1\u00a021.7 (\u22126.4\u00a0\u00b1\u00a014.9), respectively, in the 5-mg elobixibat gro"}], "id": "12784", "pmcid": "5866829", "prompt_id": "12784", "split_group_id": "5866829", "votes": {"0": 2}} |
Background
Diabetes is one of the most common metabolic disorders, with a high prevalence of patients with poor metabolic control. Worldwide, evidence highlights the importance of developing and implementing educational interventions that can reduce this burden. The main objective of this study was to analyse the impa... | Intervention: Educational Program
Comparator: usual care
Outcome: HbA1c | -1 | {"evidence_spans": [{"end": 1264, "start": 1058, "text": "sults\r\nStatistical differences were obtained between groups for HbA1c and BMI: EG had a decrease in 11% more (effect-size r2\u2009=\u2009.11) than CG for HbA1c (p\u2009<\u2009.001) and 4% more (effect-size r2\u2009=\u2009.04) in BMI (p\u2009"}, {"end": 1211, "... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.